BAR502   Click here for help

GtoPdb Ligand ID: 14680

Synonyms: BAR-502 | NorECDCOH
Compound class: Synthetic organic
Comment: BAR502 is a semi-synthetic steroidal agonist of farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (GPBAR1) [1]. It also activates MRGPRX4 [4], and has antagonist activity at the leukemia inhibitory factor receptor (LIF) receptor [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 3
Rotatable bonds 4
Topological polar surface area 60.69
Molecular weight 392.62
XLogP 6.58
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC[C@@H]1[C@@H]2C[C@@H](CC[C@]2(C)[C@H]3CC[C@]4(C)[C@H](CC[C@H]4[C@@H]3[C@@H]1O)[C@H](C)CCO)O
Isomeric SMILES CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCO)C)C)O
InChI InChI=1S/C25H44O3/c1-5-17-21-14-16(27)8-11-25(21,4)20-9-12-24(3)18(15(2)10-13-26)6-7-19(24)22(20)23(17)28/h15-23,26-28H,5-14H2,1-4H3/t15-,16-,17-,18-,19+,20+,21+,22+,23-,24-,25-/m1/s1
InChI Key HYCMOIGNYNCMRH-APIYUPOTSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. D'Amore C, Di Leva FS, Sepe V, Renga B, Del Gaudio C, D'Auria MV, Zampella A, Fiorucci S, Limongelli V. (2014)
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors.
J Med Chem, 57 (3): 937-54. [PMID:24387325]
2. Di Giorgio C, Bellini R, Lupia A, Massa C, Bordoni M, Marchianò S, Rosselli R, Sepe V, Rapacciuolo P, Moraca F et al.. (2023)
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma.
Front Oncol, 13: 1140730. [PMID:36998446]
3. Festa C, Renga B, D'Amore C, Sepe V, Finamore C, De Marino S, Carino A, Cipriani S, Monti MC, Zampella A et al.. (2014)
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands.
J Med Chem, 57 (20): 8477-95. [PMID:25247751]
4. Yeager A, Selfridge B, Sainz M, Martinborough E, Boehm M, Huang L. (2020)
Modulators of mas-related g-protein receptor x4 and related products and methods.
Patent number: WO2020198537A1. Assignee: Escient Pharmaceuticals Inc. Priority date: 26/03/2020. Publication date: 01/10/2020.